Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.
Dividends can offer fat full-time income. But the math needs to work.
Yahoo Finance Live anchors discuss reports that Apple has ditched plans to increase iPhone 14 production.
Yahoo Finance Live anchors discuss Biogen stock performance on promising Alzheimer’s drug trial data.
Shares of Nano-X Imaging (NASDAQ: NNOX), commonly called Nanox, soared on Wednesday after it revealed it's taken the next step toward commercializing its flagship medical device. As of 12:20 p.m. ET, Nanox stock was up 21%. Nanox had its initial public offering (IPO) in 2020, promising to disrupt the X-ray industry with its digital-3D imaging machines that will be cheaper for doctors to use.
General Motors CEO Mary Barra yesterday apologized to salaried workers for the timing of a memo sent late Friday afternoon outlining a new back-to-office policy and delayed the implementation of the plan. The email said that GM employees who had been working remotely during the pandemic would be required later this year to return to the office at least three days a week, the Detroit Free Press reported. The email triggered employee pushback about both the updated policy and the timing of the announcement, leading Barra to partially walk back the decision, announcing Tuesday that the automaker will not implement the requirement this year but that “a more regular, in-person presence” will still be the plan for the future.
Oil prices bounced higher on Wednesday. Notable names on the upswing today were Chevron (NYSE: CVX), Devon Energy (NYSE: DVN), Phillips 66 (NYSE: PSX), and Energy Transfer (NYSE: ET). Here's a look at what's fueling the oil market's rebound and how it impacts these companies.
Baird Senior Research Analyst Brian Skorney joins Yahoo Finance Live to discuss the breakthrough of Biogen's Alzheimer's drug, which is pushing the stock higher.
Marijuana stocks continued to rebound from last week's sell-off on Wednesday, with shares of Canopy Growth (NASDAQ: CGC) gaining 4.2%, Tilray Brands (NASDAQ: TLRY) up 4.8%, and Aurora Cannabis (NASDAQ: ACB) leading the whole pack higher with a 5.4% gain as of 1:40 p.m. ET. The Nasdaq -- to which index all three of these cannabis stocks belong -- is up 1.5% in midafternoon trading. This morning, Canopy announced that in an effort to progress from losses toward profitability, it will divest its Canadian Tweed and Tokyo Smoke retail operations and focus in the future on producing "premium" branded cannabis as a consumer packaged goods company.
Shares of beaten-down big tech stocks Nvidia (NASDAQ: NVDA), Meta Platforms (NASDAQ: META), and Palantir Technologies (NYSE: PLTR) bounced back today, rising 2%, 3.4%, and 2.8%, respectively, as of 11:34 a.m. ET. There wasn't much company specific news from these three today, but their shares being down so much on the year already, combined with some marginally favorable news this morning on interest rates and geopolitics, was enough to get their stocks moving higher. Equity investors may not have noticed, but Treasury Bond yields may be determining your stock portfolio performance this year more than you think -- especially when it comes to technology growth stocks.
In this article, we will discuss the 10 dividend paying stocks you should avoid according to Morgan Stanley’s quant screen. If you want to read about similar stocks, you can also take a look at 5 Dividend Paying Stocks You Should Avoid According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Sherry Paul: “It’s a Buying […]
Top trending stocks in after hours trading on Wednesday, September 28, 2022.
Yahoo Finance Live checks out Netflix's shares after Atlantic Equities upgrades the company's stock to "Neutral" and the streaming platform announces plans to limit password sharing.
Things are bad. But at least ‘you can eat’ one of these assets.
Biogen stock rips higher on a promising new drug. Here's what Wall Street is saying.
My children have inherited $5 million of stock from their father (whose estate has not yet been dispersed after 11 months) leaving them with a 30% or so loss of value over which they have had no control. Is there … Continue reading → The post Ask an Advisor: My Kids Inherited $5 Million. How Should They Handle It? appeared first on SmartAsset Blog.
The CBOE Volatility Index has skyrocketed 89% so far this year. Morningstar put together a list of stocks with one- and three-year betas of 0.8 or lower. Then it screened for stocks that are undervalued, according to Morningstar analysts' fair value estimates.
This semiconductor and wireless communication tech company is rapidly diversifying its revenue streams.
The current cap on yearly buys of I bonds is $10,000 per person plus $5,000 through federal tax refunds. Two senators propose raising that limit to $30,000 in total.
Petrobras is set to present its new strategic plan for the coming years in November, an executive for Brazil's state-run company said on Wednesday, hinting it should be "consistent" with the current focus on offshore oil formation known as pre-salt. During an oil and gas event in Rio de Janeiro, Petrobras' executive director of governance, Salvador Dahan, said that the company will continue "what it has been doing" in pre-salt exploration and production. "The plan continues to address our focus in Brazil and with development in the pre-salt, with a lot of investment in exploration and production, but also in the downstream (logistics segments)," he said.